Guanine nucleotide regulatory proteins, G(q) and G(i1/2), mediate platelet-activating factor-stimulated phosphoinositide metabolism in immortalized hippocampal cells

Journal of Neurochemistry

Volumn 67, Issue 4, 1996, Pages 1478-1484

  Shi, Leng Chu ^a   Wang, Hoau Yan ^a   Horwitz, Joel ^a   Friedman, Eitan ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

G protein(s); Phosphoinositide metabolism; Platelet activating factor

Indexed keywords

6 (2 CHLOROPHENYL) 9 [(3,4 DIMETHOXYPHENYL)THIOMETHYLTHIOCARBONYL] 4,7,8,10 TETRAHYDRO 1 METHYLPYRIDO[4',3':4,5]THIENO[3,2 F][1,2,4]TRIAZOLO[4,3 A][1,4]DIAZEPINE; GUANINE NUCLEOTIDE BINDING PROTEIN; PHOSPHATIDYLINOSITIDE; THROMBOCYTE ACTIVATING FACTOR;

ANIMAL CELL; ARTICLE; HIPPOCAMPUS; NERVE CELL DIFFERENTIATION; NEUROTRANSMISSION; NONHUMAN; PHOSPHOINOSITIDE METABOLISM; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DETERMINATION; PROTEIN PROTEIN INTERACTION;

ANIMALIA; IPS;

EID: 0029790107     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1996.67041478.x     Document Type: Article

References (44)

1. Ali H., Richardson R. M., Tomhave E. D., DuBose R. A., Haribabu B., and Snyderman R. (1994) Regulation of stably transfected platelet activating factor receptor in RBL-2H3 cells. J. Biol. Chem. 296, 24557-24563.
2. Avdonin P. V., Svitina-Ulitina I. V., and Kulikov V. I. (1985) Stimulation of high-affinity hormone-sensitive GTPase of human platelets by 1-O-alkyl-2-O-acetyl-sn-glyceryl-3-phosphocholine (platelet activating factor). Biochem. Biophys. Res. Commun. 131, 307-313.
3. Bernardini R., Calogero A. E., Ehrlich Y. H., Brucke T., Chrousos G. P., and Gold P. W. (1989) The alkyl-ether phospholipid platelet-activating factor is a stimulator of the hypothalamic-pituitary-adrenal axis in the rat. Endocrinology 125, 1067-1073.
4. Berridge M. J. (1987) Inositol trisphosphate as a second messenger in signal transduction. Ann. NY Acad. Sci. 494, 39-51.
5. Birkle D. L., Kurian P., Braquet P., and Bazan N. G. (1988) Platelet-activating factor antagonist BN52021 decreases accumulation of free polyunsaturated fatty acid in mouse brain during ischemia and electroconvulsive shock. J. Neurochem. 51, 1900-1905.
6. 2+ in hippocampal neurons. Neuron 9, 285-294.
7. Bussolino F., Tessari F., Turrini F., Braquet P., Camussi G., Prosdocimi M., and Bosia A. (1988) Platelet activating factor induces dopamine release in PC-12 cell line. Am. J. Physiol. 255, C559-C565.
8. Catalan R. E., Martinez A. M., Aragones M. D., Fernandez I., Lombardia M., and Miguel B. G. (1992) PAF-induced activation of polyphosphoinositide-hydrolyzing phospholipase C in cerebral cortex. Biochem. Biophys. Res. Commun. 183, 300-305.
9. Cerro S. D., Arai A., and Lynch G. (1990) Inhibition of longterm potentiation by an antagonist of platelet-activating factor receptors. Behav. Neural Biol. 54, 213-217.
10. Chau L. T., Hu C. Y., Chang W. T., and Hsu Y. S. (1992) Possible existence of two subsets of platelet-activating factor receptor to mediate polyphosphoinositide breakdown and calcium influx in neuroblastoma × glioma hybrid NG 108-15 cells. J. Neurochem. 59, 1090-1098.
11. Clark G. D., Happel L. T., Zorumski C. F., and Bazan N. G. (1992) Enhancement of hippocampal excitatory synaptic transmission by platelet-activating factor. Neuron 9, 1211-1216.
12. Domingo M. T., Spinnewyn B., Chabrier P. E., and Braquet P. (1988) Presence of specific binding sites for platelet-activating factor (PAF) in brain. Biochem. Biophys. Res. Commun. 151, 730-736.
13. Exton J. H. (1994) Phosphoinositide phospholipases and G proteins in hormone action. Annu. Rev. Physiol. 56, 349-369.
14. Frerichs K. U., Lindsberg P. J., Hallenbeck J. M., and Feuerstein G. Z. (1990) Platelet-activating factor and progressive brain damage following focal brain injury. J. Neurosurg. 73, 223-233.
15. Friedman E., Butkerait P., and Wang H. Y. (1993) Analysis of receptor-stimulated and basal guanine nucleotide binding to membrane G proteins by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Anal. Biochem. 214, 171-178.
16. 32P] ADP-ribosylation of proteins. Methods Enzymol. 195, 267-280.
17. Haslam R. J. and Banderwel M. (1982) Inhibition of platelet adenylate cyclase by 1-O-akyl-2-O-acetyl-sn-glyceryl-3-phosphoryl-choline (platelet activating factor), J. Biol. Chem. 257, 6879-6855.
18. Honda Z. I., Nakamura M., Miki I., Minami M., Watanabe T., Seyama Y., Okado H., Toh H., Ito K., Miyamoto T., and Shimizu T. (1991) Cloning by functional expression of platelet-activating factor receptor from guinea-pig lung. Nature 349, 342-346.
19. Honda Z. I., Takano T., Gotoh Y., Nishida E., Ito K., and Shimizu T. (1994) Transfected platelet-activating factor receptor activates mitogen-activated protein (MAP) kinase and MAP kinase in Chinese hamster ovary cells. J. Biol. Chem. 269, 2307-2315.
20. Hwang S. B. (1988) Identification of a second putative receptor of platelet-activating factor from human polymorphonuclear leukocytes. J. Biol. Chem. 263, 3225-3233.
21. 2+ entry by inositol phosphates - a possible mechanism. FEBS Lett. 263, 5-9.
22. Jerusalinsky D., Fin C., Quillfeldt J. A., Ferreira M. B. C., Schmitz P. K., Silva R. C. D., Walz R., Bazan N. G., Medina J. H., and Izquierdo I. (1994) Effect of antagonists of platelet-activating factor receptors on memory of inhibitory avoidance in rats. Behav. Neural Biol. 62, 1-3.
23. Jiang Z. G, Yue T. L., and Feuerstein G. (1993) Platelet-activating factor inhibits excitatory transmission in rat neostriatum. Neurosci. Lett. 155, 132-135.
24. Korchanek P. M., Dutka A. J., Kumaroo K. K., and Hallenbeck J. M. (1987) Platelet-activating factor receptor blockade enhances recovery after multifocal brain ischemia. Life Sci. 41, 2639-2644.
25. Kornecki E. and Ehrlich Y. H. (1988) Neuroregulatory and neuropathological actions of the ether-phospholipid platelet-activating factor. Science 240, 1792-1794.
26. Kumar R., Harvey S. A. K., Kester M., Hanahan D. J., and Olson M. S. (1988) Production and effects of platelet-activating factor in the brain. Biochim. Biophys. Acta 963, 375-383.
27. 2 production in intact fetal rat brain ex vivo. J. Pharmacol. Exp. Ther. 263, 562-568.
28. Lindsberg P. J., Yue T. L., Frerichs K. U., Hallenbeck J. M., and Feuerstein G. (1990) Evidence for platelet-activating factor as a novel mediator in experimental stroke in rabbits. Stroke 21, 1452-1457.
29. Marcheselli V. L. and Bazan N. G. (1994) Platelet-activating factor is a messenger in electroconvulsive shock-induced transcriptional activation of c-fos and zif-268 in hippocampus. J. Neurosci. Res. 37, 54-61.
30. Marcheselli V. L., Rossowska M. J., Domingo M. T., Braquet P., and Bazan N. G. (1990) Distinct platelet-activating factor binding sites in synaptic endings and intracellular membranes of rat cerebral cortex. J. Biol. Chem. 265, 9140-9145.
31. Miyamoto A., Kowatch M. A., and Roth G. S. (1993) Similar effects of saponin treatment and aging on coupling of α1-adrenergic receptor-G-protein. Exp. Gerontol. 28, 349-359.
32. Mutoh H., Bito H., Minami M., Nakamura M., Honda Z., Izumi T., Nakata R., Kurachi Y., Terano A. and Shimizu T. (1993) Two different promoters direct expression of two distinct forms of mRNAs of human platelet-activating factor receptor. FEBS Lett. 322, 129-134.
33. Panetta T., Marcheselli V. L., Braquet P., Spinnewyn B., and Bazan N. G. (1987) Effects of a platelet-activating factor antagonist (BN52021) on free fatty acids, diacylglycerols, polyphosphoinositides and blood flow in the gerbil brain: inhibition of ischemia-reperfusion induced cerebral injury. Biochem. Biophys. Res. Commun. 149, 580-587.
34. Prehn J. H. M. and Krieglstein J. (1993) Platelet-activating factor antagonists reduce excitotoxic damage in cultured neurons from embryonic chick telencephalon and protect the rat hippocampus and neocortex from ischemic injury in vivo. J. Neurosci. Res. 34, 179-188.
35. Rhee S. G., Suh P. G., Ryu S. H., and Lee S. Y. (1989) Studies of inositol phospholipid-specific phospholipase C. Science 244, 546-550.
36. Spinnewyn B., Blavet N., Clostre F., Bazan N., and Braquet P. (1987) Involvement of platelet-activating factor (PAF) in cerebral post-ischemic phase in mongolian gerbils. Prostaglandins 34, 337-349.
37. Squinto S. P., Block A. L., Braquet P., and Bazan N. G. (1989) Platelet-activating factor stimulates a fos/jun/Ap-1 transcriptional signaling system in human neuroblastoma cells. J. Neurosci. Res. 24, 558-566.
38. Sternweis P. C. and Smrcka A. V. (1993) G proteins in signal transduction: the regulation of phospholipase C. Ciba Found. Symp. 176, 96-106.
39. Sun D., Kintner D., Fitzpatrick J. H., Emoto S. E., Braquet P. G., Bazan N. G., and Gilboe D. D. (1994) The effect of a free radical scavenger and platelet-activating factor antagonist on FFA accumulation in post-ischemic canine brain. Neurochem. Res. 19, 525-528.
40. Undie A. S. and Friedman E. (1990) Stimulation of a dopamine DI receptor enhances inositol phosphate formation in rat brain. J. Pharmacol. Exp. Ther. 253, 987-992.
41. i protein. J. Neurochem. 63, 1720-1725.
42. Yue T.-L., Gleason M. M., Gu J. L., Lysko P. G., Hallenbeck J., and Feuerstein G. (1991a) Platelet-activating factor (PAF) receptor-mediated calcium mobilization and phosphoinositide turnover in neurohybrid NG108-15 cells: studies with BN50739, a new PAF antagonist. J. Pharmacol. Exp. Ther. 257, 374-381.
43. Yue T.-L., Gleason M. M., Hallenbeck J., and Feuerstein G. (1991b) Characterization of platelet-activating factor-induced elevation of cytosolic free-calcium level in neurohybrid NCB-20 cells. Neuroscience 41, 177-185.
44. Yue T.-L., Stadel J. M., Sarau H. M., Friedman E., Gu J. L., Powers D. A., Gleason M. M., Feuerstein G., and Wang H.-Y. (1992) Platelet-activating factor stimulates phosphoinositide turnover in neurohybrid NCB-20 cells: involvement of pertussis toxin-sensitive guanine nucleotide-binding proteins and inhibition by protein kinase C. Mol. Pharmacol. 41, 281-289.